Placental cells for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests whether a special treatment using placental cells can help heal diabetic foot ulcers that haven't healed with standard care. If you qualify, you may receive this cell-based treatment to see if it helps your wound close faster and reduce the risk of complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes for at least one year.
- Your foot ulcer should be between 2 and 4 square centimeters (about the size of a small coin to a large coin).
- The ulcer must have been present for at least four weeks despite standard care.
- You must be able to use a special boot or cast to keep pressure off the ulcer.
- You must not have an active infection in the ulcer that requires antibiotics.
- Your blood sugar control should be within a certain range (HbA1c below 12% or good time-in-range).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special placental tissue graft placed on a diabetic foot ulcer helps it heal faster than standard wound care alone. It is for people with a diabetic foot ulcer that has not healed after 4 weeks of usual care.
This trial tests whether stem cells taken from your own fat tissue can help heal foot ulcers caused by diabetes. The cells are applied to the wound, and the goal is to see if they improve healing and are safe.
This study tests whether a special wound dressing made from human placental membrane can help heal diabetic foot ulcers or venous leg ulcers that did not close with standard care. It is for people who were in the BIOCAMP trial and whose ulcer remained open after 12 weeks of standard treatment.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This trial tests if a placental membrane product, when added to standard wound care, helps heal diabetic foot ulcers and venous leg ulcers faster than standard care alone.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.